Malignant Pleural Mesothelioma: Analysis of 70 Cases in the Last Decade.
作者信息
Garcia-Prieto Fernando, Pardo Sara Calero, Ramírez María Teresa Río, Fernández Araceli Abad
机构信息
Profesor colaborador Universidad Europea de Madrid, Hospital Universitario de Getafe, Autovía Madrid-Toledo Km 12.5, 28095 Getafe, Madrid, Spain.
Profesora Asociada de la Universidad Europea de Madrid, Hospital Universitario de Getafe, Autovía Madrid-Toledo Km 12.5, 28095 Getafe, Madrid, Spain.
出版信息
Open Respir Arch. 2024 Apr 23;6(2):100326. doi: 10.1016/j.opresp.2024.100326. eCollection 2024 Apr-Jun.
Abstract
摘要
相似文献
1
Malignant Pleural Mesothelioma: Analysis of 70 Cases in the Last Decade.恶性胸膜间皮瘤：过去十年70例病例分析
Open Respir Arch. 2024 Apr 23;6(2):100326. doi: 10.1016/j.opresp.2024.100326. eCollection 2024 Apr-Jun.
2
Diffuse malignant pleural mesothelioma in an urban hospital: clinical spectrum and trend in incidence over time.城市医院中的弥漫性恶性胸膜间皮瘤：临床谱及发病率随时间的变化趋势
Am J Ind Med. 1989;16(4):373-83. doi: 10.1002/ajim.4700160405.
3
[Pleural effusion cytology of asbestos-associated malignant mesothelioma and lung carcinoma in the diagnosis of occupational diseases by the statutory accident insurance funds].[法定事故保险基金在职业病诊断中石棉相关恶性间皮瘤和肺癌的胸腔积液细胞学检查]
Pneumologie. 2014 Apr;68(4):270-6. doi: 10.1055/s-0034-1365157. Epub 2014 Mar 10.
4
Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining.
Virchows Arch A Pathol Anat Histol. 1982;397(3):287-99. doi: 10.1007/BF00496570.
5
Extended pleurectomy decortication for the treatment of malignant pleural mesothelioma.扩大胸膜剥脱术治疗恶性胸膜间皮瘤
Multimed Man Cardiothorac Surg. 2019 Nov 5;2019. doi: 10.1510/mmcts.2019.023.
6
Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.恶性胸膜间皮瘤转移至纵隔淋巴结的不寻常特征。
Appl Immunohistochem Mol Morphol. 2008 May;16(3):301-7. doi: 10.1097/PAI.0b013e3181507893.
7
Pleural and pericardial mesothelioma in a general teaching hospital during the last fourteen years.过去十四年中一所综合教学医院的胸膜和心包间皮瘤情况。
Zhonghua Yi Xue Za Zhi (Taipei). 1994 Aug;54(2):100-4.
8
Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium.免疫细胞化学检测 CD146 有助于鉴别恶性胸膜间皮瘤和反应性间皮组织。
Mod Pathol. 2010 Nov;23(11):1458-66. doi: 10.1038/modpathol.2010.134. Epub 2010 Jul 23.
9
Advances in pleuroscopy.胸腔镜检查的进展
Clin Respir J. 2018 Mar;12(3):839-847. doi: 10.1111/crj.12597. Epub 2017 Jan 11.
10
Localized malignant pleural mesothelioma: report of two cases.局限性恶性胸膜间皮瘤：2例报告
J Thorac Oncol. 2009 Aug;4(8):1038-40. doi: 10.1097/JTO.0b013e3181a8c874.
本文引用的文献
1
The cytologic diagnosis of mesothelioma: are we there yet?间皮瘤的细胞学诊断：我们做到了吗？
J Am Soc Cytopathol. 2023 Mar-Apr;12(2):89-104. doi: 10.1016/j.jasc.2022.12.001. Epub 2022 Dec 26.
2
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.恶性胸膜间皮瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2022 Feb;33(2):129-142. doi: 10.1016/j.annonc.2021.11.005. Epub 2021 Nov 30.
3
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis.诊断生物标志物在恶性胸膜间皮瘤中的临床应用：系统评价和荟萃分析。
Eur Respir Rev. 2021 Nov 17;30(162). doi: 10.1183/16000617.0057-2021. Print 2021 Dec 31.
4
Perspectives on the Treatment of Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的治疗前景
N Engl J Med. 2021 Sep 23;385(13):1207-1218. doi: 10.1056/NEJMra1912719.
5
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab.一项在恶性胸膜疾病患者中联合抗 PD-1 药物 Pembrolizumab 进行局部间皮素靶向 CAR T 细胞治疗的 I 期临床试验。
Cancer Discov. 2021 Nov;11(11):2748-2763. doi: 10.1158/2159-8290.CD-21-0407. Epub 2021 Jul 15.
6
Does size matter? -a population-based analysis of malignant pleural mesothelioma.大小很重要吗？——基于人群的恶性胸膜间皮瘤分析
Transl Lung Cancer Res. 2020 Aug;9(4):1041-1052. doi: 10.21037/tlcr-19-488.
7
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma.间皮瘤与根治性手术2（MARS 2）：一项多中心随机试验的方案，该试验比较（扩大）胸膜剥脱术与未行（扩大）胸膜剥脱术治疗恶性胸膜间皮瘤患者的效果。
BMJ Open. 2020 Sep 1;10(9):e038892. doi: 10.1136/bmjopen-2020-038892.
8
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.ERS/ESTS/EACTS/ESTRO 指南：恶性胸膜间皮瘤的管理。
Eur Respir J. 2020 Jun 11;55(6). doi: 10.1183/13993003.00953-2019. Print 2020 Jun.
9
Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.尼达尼布联合培美曲塞和顺铂用于未经化疗的晚期恶性胸膜间皮瘤患者（LUME-Meso）：一项双盲、随机、安慰剂对照的 3 期临床试验。
Lancet Respir Med. 2019 Jul;7(7):569-580. doi: 10.1016/S2213-2600(19)30139-0. Epub 2019 May 15.
10
Diagnosis and characterization of malignant effusions through pleural fluid cytological examination.通过胸腔积液细胞学检查诊断和鉴别恶性胸腔积液。
Curr Opin Pulm Med. 2019 Jul;25(4):362-368. doi: 10.1097/MCP.0000000000000593.
Zotero 插件